nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—trigeminal nerve—bone cancer	0.132	0.813	CbGeAlD
Clenbuterol—NGF—spinal cord—bone cancer	0.0128	0.0793	CbGeAlD
Clenbuterol—ADRB3—connective tissue—bone cancer	0.0123	0.0762	CbGeAlD
Clenbuterol—ADRB1—connective tissue—bone cancer	0.00505	0.0311	CbGeAlD
Clenbuterol—NGF—Signaling by NGF—ATF1—bone cancer	0.00465	0.00556	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00463	0.00554	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—MET—bone cancer	0.00453	0.00542	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00453	0.00542	CbGpPWpGaD
Clenbuterol—ADRB3—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00436	0.00521	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.00433	0.00518	CbGpPWpGaD
Clenbuterol—CYP1A1—Estrogen Receptor Pathway—JUN—bone cancer	0.00429	0.00513	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.00413	0.00494	CbGpPWpGaD
Clenbuterol—TNF—FAS pathway and Stress induction of HSP regulation—RB1—bone cancer	0.00413	0.00494	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Other—SMO—bone cancer	0.0041	0.00491	CbGpPWpGaD
Clenbuterol—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.00391	0.00468	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP9—bone cancer	0.00389	0.00466	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00384	0.00459	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—BRAF—bone cancer	0.0038	0.00455	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—TP53—bone cancer	0.00373	0.00446	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—RB1—bone cancer	0.00371	0.00444	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP9—bone cancer	0.0037	0.00443	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1R—bone cancer	0.00354	0.00423	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—IGF1R—bone cancer	0.00354	0.00423	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.00344	0.00412	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.00344	0.00412	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—GRM4—bone cancer	0.00328	0.00392	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—EGFR—bone cancer	0.00327	0.00392	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00323	0.00387	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.00323	0.00387	CbGpPWpGaD
Clenbuterol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00317	0.0038	CbGpPWpGaD
Clenbuterol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00316	0.00378	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00315	0.00378	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—JUN—bone cancer	0.00313	0.00375	CbGpPWpGaD
Clenbuterol—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00312	0.00373	CbGpPWpGaD
Clenbuterol—TNF—FAS pathway and Stress induction of HSP regulation—JUN—bone cancer	0.00306	0.00366	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—JUN—bone cancer	0.00306	0.00366	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—MMP9—bone cancer	0.00298	0.00356	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bone cancer	0.00295	0.00353	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—JUN—bone cancer	0.00294	0.00352	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—bone cancer	0.00292	0.0035	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.00292	0.0035	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00284	0.0034	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—GRM1—bone cancer	0.00284	0.0034	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—JUN—bone cancer	0.00277	0.00332	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00275	0.00329	CbGpPWpGaD
Clenbuterol—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00273	0.00327	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.00271	0.00324	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.00266	0.00318	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—KIT—bone cancer	0.00264	0.00317	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00259	0.0031	CbGpPWpGaD
Clenbuterol—Salbutamol—CYP3A4—bone cancer	0.00258	1	CrCbGaD
Clenbuterol—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00256	0.00307	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00253	0.00303	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.0025	0.003	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—JUN—bone cancer	0.0025	0.00299	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.00249	0.00298	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—BRAF—bone cancer	0.00249	0.00298	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—EGFR—bone cancer	0.00229	0.00275	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00228	0.00273	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00225	0.00269	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.00224	0.00268	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.00224	0.00268	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—bone cancer	0.00219	0.00262	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—EGFR—bone cancer	0.00218	0.00261	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFBR2—bone cancer	0.00216	0.00259	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—JUN—bone cancer	0.00213	0.00255	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00211	0.00252	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—MDM2—bone cancer	0.00208	0.00249	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CDK4—bone cancer	0.00208	0.00249	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MDM2—bone cancer	0.00202	0.00242	CbGpPWpGaD
Clenbuterol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00201	0.00241	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—SMO—bone cancer	0.002	0.0024	CbGpPWpGaD
Clenbuterol—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00199	0.00238	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—GRM4—bone cancer	0.00195	0.00233	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GRM4—bone cancer	0.00192	0.0023	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RGS1—bone cancer	0.00192	0.0023	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.0019	0.00228	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—GRM4—bone cancer	0.0019	0.00228	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—bone cancer	0.00188	0.00225	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GRM4—bone cancer	0.00185	0.00222	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RGS1—bone cancer	0.00185	0.00222	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.00185	0.00222	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—bone cancer	0.00183	0.00219	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—RB1—bone cancer	0.00181	0.00216	CbGpPWpGaD
Clenbuterol—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.0018	0.00215	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—JUN—bone cancer	0.00176	0.0021	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00173	0.00207	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—GRM1—bone cancer	0.00169	0.00202	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GRM4—bone cancer	0.00168	0.00201	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RGS1—bone cancer	0.00168	0.00201	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—RB1—bone cancer	0.00167	0.002	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GRM1—bone cancer	0.00167	0.00199	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—GRM1—bone cancer	0.00165	0.00198	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—JUN—bone cancer	0.00163	0.00195	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00163	0.00195	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.00162	0.00194	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GRM1—bone cancer	0.00161	0.00192	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00156	0.00187	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.0015	0.0018	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—bone cancer	0.00148	0.00178	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GRM1—bone cancer	0.00146	0.00175	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—EGFR—bone cancer	0.00142	0.0017	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00141	0.00169	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—bone cancer	0.00141	0.00168	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—BRAF—bone cancer	0.00139	0.00166	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.00136	0.00163	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00134	0.00161	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.00134	0.00161	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—bone cancer	0.0013	0.00156	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.00127	0.00152	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.00123	0.00147	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.00123	0.00147	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—bone cancer	0.00122	0.00146	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—SMO—bone cancer	0.00119	0.00142	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.00117	0.00141	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SMO—bone cancer	0.00117	0.0014	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.00116	0.00139	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—SMO—bone cancer	0.00116	0.00139	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—bone cancer	0.00116	0.00139	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.00115	0.00137	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.00114	0.00137	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.0011	0.00132	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GRM4—bone cancer	0.0011	0.00132	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RGS1—bone cancer	0.0011	0.00132	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RGS1—bone cancer	0.00108	0.00129	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GRM4—bone cancer	0.00108	0.00129	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GNA11—bone cancer	0.00107	0.00129	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—JUN—bone cancer	0.00107	0.00128	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—EGFR—bone cancer	0.00105	0.00126	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00105	0.00125	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GNA11—bone cancer	0.00104	0.00124	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.00103	0.00124	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—SMO—bone cancer	0.00103	0.00123	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00101	0.00121	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—JUN—bone cancer	0.00101	0.00121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GRM4—bone cancer	0.000999	0.0012	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RGS1—bone cancer	0.000999	0.0012	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ATF1—bone cancer	0.000998	0.00119	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000995	0.00119	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GRM4—bone cancer	0.000994	0.00119	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RGS1—bone cancer	0.000994	0.00119	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RGS1—bone cancer	0.000977	0.00117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GRM4—bone cancer	0.000977	0.00117	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL3—bone cancer	0.000973	0.00117	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GRM1—bone cancer	0.000954	0.00114	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNA11—bone cancer	0.00094	0.00113	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL3—bone cancer	0.000939	0.00112	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GRM1—bone cancer	0.000933	0.00112	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00091	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—bone cancer	0.000883	0.00106	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000867	0.00104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GRM1—bone cancer	0.000866	0.00104	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GRM1—bone cancer	0.000862	0.00103	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000855	0.00102	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL3—bone cancer	0.000852	0.00102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GRM1—bone cancer	0.000847	0.00101	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFBR2—bone cancer	0.000832	0.000996	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NDUFA12—bone cancer	0.000815	0.000976	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—bone cancer	0.000793	0.000949	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1R—bone cancer	0.000783	0.000937	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000782	0.000937	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000782	0.000937	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTP1—bone cancer	0.000742	0.000888	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	0.000732	0.000876	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000716	0.000857	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—bone cancer	0.00071	0.00085	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NT5C3A—bone cancer	0.000676	0.000809	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—bone cancer	0.000666	0.000797	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MET—bone cancer	0.000661	0.000791	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CDK4—bone cancer	0.000661	0.000791	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNA11—bone cancer	0.000614	0.000736	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—SMO—bone cancer	0.00061	0.00073	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SMO—bone cancer	0.000607	0.000727	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNA11—bone cancer	0.000601	0.00072	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000601	0.000719	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—SMO—bone cancer	0.000597	0.000714	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RGS1—bone cancer	0.00059	0.000706	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM4—bone cancer	0.00059	0.000706	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RGS1—bone cancer	0.000577	0.000691	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM4—bone cancer	0.000577	0.000691	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KIT—bone cancer	0.000568	0.00068	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNA11—bone cancer	0.000558	0.000668	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL3—bone cancer	0.000557	0.000667	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNA11—bone cancer	0.000555	0.000665	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—bone cancer	0.000551	0.00066	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNA11—bone cancer	0.000546	0.000653	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL3—bone cancer	0.000545	0.000652	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—BRAF—bone cancer	0.000534	0.000639	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NDUFA12—bone cancer	0.00052	0.000622	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ATF1—bone cancer	0.000516	0.000618	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM1—bone cancer	0.000512	0.000612	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL3—bone cancer	0.000506	0.000606	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL3—bone cancer	0.000503	0.000603	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM1—bone cancer	0.0005	0.000599	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL3—bone cancer	0.000495	0.000592	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MDM2—bone cancer	0.000447	0.000535	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NT5C3A—bone cancer	0.000431	0.000516	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFBR2—bone cancer	0.000431	0.000515	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—bone cancer	0.000414	0.000496	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1R—bone cancer	0.000405	0.000485	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JUN—bone cancer	0.000389	0.000465	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—bone cancer	0.000378	0.000453	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SMO—bone cancer	0.00036	0.000431	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SMO—bone cancer	0.000353	0.000422	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—bone cancer	0.000335	0.000401	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNA11—bone cancer	0.00033	0.000395	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNA11—bone cancer	0.000322	0.000386	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ATF1—bone cancer	0.000306	0.000367	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—bone cancer	0.000306	0.000366	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ATF1—bone cancer	0.0003	0.000359	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL3—bone cancer	0.000299	0.000358	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ENO2—bone cancer	0.000296	0.000354	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KIT—bone cancer	0.000294	0.000352	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL3—bone cancer	0.000292	0.00035	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BRAF—bone cancer	0.000276	0.000331	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DHFR—bone cancer	0.000275	0.000329	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—bone cancer	0.000268	0.00032	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—bone cancer	0.000257	0.000307	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNA11—bone cancer	0.000257	0.000307	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFBR2—bone cancer	0.000256	0.000306	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFBR2—bone cancer	0.00025	0.000299	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1R—bone cancer	0.00024	0.000288	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1R—bone cancer	0.000235	0.000282	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP3A4—bone cancer	0.000233	0.000278	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000231	0.000277	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—bone cancer	0.000231	0.000277	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JUN—bone cancer	0.000201	0.000241	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—bone cancer	0.000199	0.000238	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—bone cancer	0.000196	0.000234	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO2—bone cancer	0.000189	0.000226	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DHFR—bone cancer	0.000175	0.00021	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KIT—bone cancer	0.000174	0.000209	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KIT—bone cancer	0.000171	0.000204	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BRAF—bone cancer	0.000164	0.000196	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNA11—bone cancer	0.000164	0.000196	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BRAF—bone cancer	0.00016	0.000192	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—bone cancer	0.000159	0.00019	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—bone cancer	0.000158	0.000189	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—bone cancer	0.000155	0.000186	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP3A4—bone cancer	0.000148	0.000178	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000148	0.000177	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—bone cancer	0.000137	0.000164	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—bone cancer	0.000134	0.000161	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—bone cancer	0.000133	0.000159	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—bone cancer	0.000127	0.000152	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JUN—bone cancer	0.000119	0.000143	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JUN—bone cancer	0.000117	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—bone cancer	0.000116	0.000139	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—bone cancer	0.000114	0.000136	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—bone cancer	0.000103	0.000123	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—bone cancer	9.39e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—bone cancer	9.18e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—bone cancer	7.88e-05	9.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—bone cancer	7.71e-05	9.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—bone cancer	6.57e-05	7.87e-05	CbGpPWpGaD
